Find Locations
For hours, walk-ins and appointments.
Let Labcorp be your source for neurodegenerative insights.
Labcorp believes in harnessing science to improve the health and lives of people with neurodegenerative diseases, such as Alzheimer’s and multiple sclerosis.
Labcorp offers comprehensive testing options across the neurodegenerative spectrum
Neurofilament Light Chain (NfL) Test
NfL is a well-studied blood biomarker test that is now widely available through Labcorp for assessing neuronal damage from neurodegenerative diseases and sports-related concussion.
Glial Fibrillary Acidic Protein (GFAP)
GFAP is a protein expressed mostly in astrocytes in the brain that has utility in predicting disability progression in multiple sclerosis, determining the extent of damage in traumatic brain injury events and, in conjunction with markers of amyloid pathology, has been shown to be a predictor of Alzheimer’s disease.
Advancing Alzheimer's disease diagnostics
Finding a way to diagnose Alzheimer's earlier and easier is a key goal for Labcorp.
Multiple Sclerosis (MS)
While no single test can diagnose multiple sclerosis, lab tests may help doctors rule out other diseases and confirm a diagnosis.
ALS / Ataxias / Huntington’s disease
Genetics can play a significant role in the development of certain neurodegenerative diseases. In some cases, genetic testing may help confirm a diagnosis.
Muscular Dystrophy
Characterized by progressive muscle loss and weakness, our tests can detect the genetic mutations that cause the most common forms.
Helping develop new biopharma breakthroughs
The increasing prevalence of neurodegenerative diseases has fueled the need for advanced research into therapeutic solutions and related neurodegenerative biomarkers.